Healthcare -
Biotechnology - NASDAQ - US
$ 0.53
-3.46 %
$ 2.51 M
Market Cap
-0.11
P/E
PCSA - CASH & EQUIVALENTS
Cash & Equivalents PCSA - Processa Pharmaceuticals, Inc.
4.71 M
LAST VALUE
-46.59%
2 YEAR CAGR
22.00%
5 YEAR CAGR
38.07%
10 YEAR CAGR